Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Specials Make Israelpharm.com the Place to Buy Name Brand Medication Online Safely and Securely
  • USA - English


News provided by

On Call News

Jul 26, 2013, 14:35 ET

Share this article

Share toX

Share this article

Share toX

Buy Brand Medication online safely and securely at https://www.israelpharm.com
Buy Brand Medication online safely and securely at https://www.israelpharm.com

BET SHEMESH, ISRAEL (PRWEB) July 26, 2013 -- American consumers can now save 50 percent or more on the highest quality name brand and generic prescription drugs when they order them online from Israelpharm at https://www.Israelpharm.com. Israelpharm is the leading secure online pharmacy and meets all requirements for authorized discounted online medicine sales.

Israelpharm is now offering brand name prescription medications with discounts of 50 percent or more online at https://www.israelpharm.com.

Post this

American consumers are discovering that there is no need to pay inflated prices for prescription drugs when they can take advantage of Israelpharm’s discount prices and impeccable record for quality control, which makes it the most secure supplier for medications, particularly in times when many health insurance carriers are reducing prescription benefits or drastically increasing co-pays. Israelpharm is the perfect alternative to pay significantly reduced rates on medications such as Androgel, Motilium Advair, , Lipitor, Keppra, Januvia, Lexapro, Lyrica, , Nexium, Provigil, Plavix, Reclast, and other high demand products including low T supplements. All of the hundreds of medications offered by Israelpharm are detailed with complete descriptions, and cost listings are listed on-line in an easy-to-use drop down menu that enables the user to locate desired medications and place orders in one step with the convenience of never having to stand in lines at local pharmacies.

Israelpharm’s discount prescription drugs can be ordered by American shoppers with complete confidence in the company’s reputation for insisting upon the highest level of quality control and customer service as it meets or exceeds all professional standards. Israelpharm is located in Bet Shemesh, between Jerusalem and Tel Aviv, and is fully licensed and regulated by Israel’s demanding standards for the manufacturing and exporting of pharmaceuticals, as well as meeting all US, Customs regulations for the importation of prescription drugs. They are able to sell prescription drugs for a fraction of the prices charged by U.S. pharmacies because, unlike in America, prescription prices are limited and regulated by the Israeli government. The price restrictions apply to all products imported as well as sold in Israel, so Israelpharm is able to provide medications online without the inflated prices charged by American pharmacy companies.

Israelpharm’s discount prescription consumers have the security of knowing that their medications are all fully regulated, licensed, and registered, unlike many so-called on line pharmaceutical providers. Many American online consumers have had the misfortune to discover that a large number of foreign Internet pharmacy companies, including many claiming to be operating out of Canada, sell unsuspecting customers inferior products that do meet U.S. standards and actually cannot be purchased legally in some states. Such sales led the U.S. government to recently crack down on online prescription drug sales and shut down the Internet sites of over a thousand companies selling products that do not meet U.S. standards.

Israelpharm, however, can assure American online buyers that every drug, cosmetic, and other product listed on its website is approved by the Israeli government’s Ministry of Health, and often the products ordered will be the exact same product that would be received in the U.S. The Israeli Ministry of Health imposes the most stringent manufacturing standards for all pharmaceuticals sold in Israel and Israelpharm’s products are fully authorized for exportation to the U.S.

Customers’ confidentiality is protected in all prescription orders delivered directly to the buyer’s door using the EMS Postal Service through the Israeli Post Office. Online customers are provided with tracking numbers that enables them to monitor the progress of shipments on-line through the process of the delivery of their orders.

Israelpharm’s position as a leading secure source for medications is reflected in its policy that all orders must be accompanied by a U.S. doctor’s prescription, unlike many foreign online prescription mills. Many non-US suppliers claim to have “doctors” on staff that write prescription orders online (without seeing the patient or being able to physically verify the legitimacy of the need for the medication) when the buyer answers a few superficial, often ambiguous questions when placing an order. Israeli law requires a valid, legitimate prescription with no changes and that has been written within 12 months of placing an order. Israelpharm will not fill any order without a legitimate U.S. prescription that meets these legal requirements. Buyers are also required to complete an online questionnaire that requires medical history, an inventory of current medications being taken, and verification of the buyer’s address and phone number. Israelpharm cannot accept digital prescriptions or pharmacy transfer prescriptions under law.

Qualifying prescriptions must be faxed (toll free) to 1-866-544-8993 or emailed to perscriptions(at)Israelpharm(dot)com in their original form. Israelpharm encourages online customers to order prescriptions in three-month supplies (the maximum allowed for any prescription order by U.S. regulations, whether ordered from a foreign or domestic pharmacy) in order to save shipping expenses. All orders are shipped from Israel for a flat rate of $20, regardless of their size or quantity. All orders to U.S. customers are shipped via express mail with most delivery times under 10 days.

Media Relations, On Call News, 310-498-9303, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.